Episode Details
Back to Episodes
Mounjaro May Cut Heart Attack Risk | Sheffield News
Description
New research reveals Mounjaro might slash heart attack risk by 33% in type two diabetes patients also battling heart disease—based on a massive real-world study of nearly 53,000 people. Compared to sitagliptin, Mounjaro not only reduced major cardiovascular events but also cut hospitalizations for infections and overall deaths. While stroke benefits weren’t significant, the findings offer powerful evidence that this drug may deliver broader health advantages beyond blood sugar control—helping doctors and patients make smarter, more informed choices.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/03cdabe20333aa77